CLINICAL_TRIALS trial_result · 2023-09-11

Clinical Trial Update: Inflammation Inhibition in Prediabetic Humans [Phase 2]

Phase 2 trial in prediabetic and obese individuals studying inflammation inhibition was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Gary L. Pierce | Conditions: Prediabetes, Obese | Phase 2 | Status: TERMINATED | Results posted: 2023-09-11